CGMP Travoprost

Travoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF for Travoprost is on file with the US FDA, Canada, India, China, in several EU member states, and in several other countries.